The EMA said 30 drugs across four therapeutic classes have received conditional marketing authorization in the EU since the expedited approval pathway became available a decade ago.
Source: International Pharmaceutical Regulatory Monitor
The EMA said 30 drugs across four therapeutic classes have received conditional marketing authorization in the EU since the expedited approval pathway became available a decade ago.
Source: International Pharmaceutical Regulatory Monitor